Vanda Pharmaceuticals (VNDA) Assets Average (2011 - 2026)

Vanda Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $461.2 million for Q1 2026.

• In Q1 2026, Assets Average fell 28.39% year-over-year to $461.2 million; the TTM figure through Mar 2026 stood at $461.2 million (down 28.39% YoY), while the FY2025 annual figure was $572.6 million, down 12.22% from the prior year.
• Assets Average came in at $461.2 million for Q1 2026 at Vanda Pharmaceuticals, down from $545.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $652.0 million in Q2 2024 to a low of $461.2 million in Q1 2026.
• A 5-year average of $618.3 million and a median of $639.4 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average increased 11.21% in 2022 and decreased 28.39% in 2026, its largest moves.
• Vanda Pharmaceuticals' Assets Average stood at $628.0 million in 2022, then rose by 2.71% to $645.0 million in 2023, then rose by 0.87% to $650.7 million in 2024, then dropped by 16.23% to $545.0 million in 2025, then retreated by 15.38% to $461.2 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $461.2 million, $545.0 million, and $612.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison